|
GLMN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.928380E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.978460E-02 |
| Normal-vs-Stage2 |
1.788420E-01 |
| Normal-vs-Stage3 |
1.757010E-01 |
| Normal-vs-Stage4 |
7.558000E-02 |
| Stage1-vs-Stage2 |
8.867600E-01 |
| Stage1-vs-Stage3 |
6.133600E-01 |
| Stage1-vs-Stage4 |
7.945000E-01 |
| Stage2-vs-Stage3 |
6.545400E-01 |
| Stage2-vs-Stage4 |
7.862400E-01 |
| Stage3-vs-Stage4 |
8.026000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.102200E-02 |
| Normal-vs-AfricanAmerican |
1.729430E-01 |
| Normal-vs-Asian |
7.654400E-01 |
| Caucasian-vs-AfricanAmerican |
6.697200E-01 |
| Caucasian-vs-Asian |
6.933800E-01 |
| AfricanAmerican-vs-Asian |
7.221600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.086570E-01 |
| Normal-vs-Female |
2.841700E-03 |
| Male-vs-Female |
5.491600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.428000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.149800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.839960E-02 |
| Normal-vs-Age(81-100Yrs) |
5.822100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.815000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.359200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.197000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.574200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.819200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.297400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.006190E-01 |
| Normal-vs-Grade 2 |
2.575500E-03 |
| Normal-vs-Grade 3 |
2.444600E-01 |
| Normal-vs-Grade 4 |
2.687800E-01 |
| Grade 1-vs-Grade 2 |
8.253200E-01 |
| Grade 1-vs-Grade 3 |
2.932200E-01 |
| Grade 1-vs-Grade 4 |
3.701400E-01 |
| Grade 2-vs-Grade 3 |
1.375760E-02 |
| Grade 2-vs-Grade 4 |
6.338000E-02 |
| Grade 3-vs-Grade 4 |
8.565800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.424700E-04 |
| Normal-vs-ccB subtype |
7.651800E-01 |
| ccA subtype-vs-ccB subtype |
6.831500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.551600E-02 |
| Normal-vs-N1 |
6.773200E-01 |
| N0-vs-N1 |
2.487600E-01 |
|
|
